These studies have motivated further investigations in other cancer models, including prostate cancer, given that prostate-specific antigen levels are not a reliable indicator of either the early phases or the recurrence of prostate cancer, whereas the prostasomes released by prostate cancer cells may act as a biomarker. Here, KLK3 is linked to prostate carcinoma.